JP2024522086A5 - - Google Patents
Info
- Publication number
- JP2024522086A5 JP2024522086A5 JP2023572062A JP2023572062A JP2024522086A5 JP 2024522086 A5 JP2024522086 A5 JP 2024522086A5 JP 2023572062 A JP2023572062 A JP 2023572062A JP 2023572062 A JP2023572062 A JP 2023572062A JP 2024522086 A5 JP2024522086 A5 JP 2024522086A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- manipulated
- ribonucleic acid
- guide ribonucleic
- sequence identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163196127P | 2021-06-02 | 2021-06-02 | |
| US63/196,127 | 2021-06-02 | ||
| US202163233653P | 2021-08-16 | 2021-08-16 | |
| US63/233,653 | 2021-08-16 | ||
| US202163261436P | 2021-09-21 | 2021-09-21 | |
| US63/261,436 | 2021-09-21 | ||
| US202163262169P | 2021-10-06 | 2021-10-06 | |
| US63/262,169 | 2021-10-06 | ||
| US202163280026P | 2021-11-16 | 2021-11-16 | |
| US63/280,026 | 2021-11-16 | ||
| US202263299664P | 2022-01-14 | 2022-01-14 | |
| US63/299,664 | 2022-01-14 | ||
| US202263308766P | 2022-02-10 | 2022-02-10 | |
| US63/308,766 | 2022-02-10 | ||
| US202263323014P | 2022-03-23 | 2022-03-23 | |
| US63/323,014 | 2022-03-23 | ||
| US202263331076P | 2022-04-14 | 2022-04-14 | |
| US63/331,076 | 2022-04-14 | ||
| PCT/US2022/031849 WO2022256462A1 (en) | 2021-06-02 | 2022-06-01 | Class ii, type v crispr systems |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522086A JP2024522086A (ja) | 2024-06-11 |
| JP2024522086A5 true JP2024522086A5 (cg-RX-API-DMAC7.html) | 2025-06-03 |
Family
ID=84324553
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023572062A Pending JP2024522086A (ja) | 2021-06-02 | 2022-06-01 | クラスii、v型crispr系 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240218339A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4347816A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024522086A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240017367A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022284808A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023024983A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3219187A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023014356A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022256462A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021178933A2 (en) | 2020-03-06 | 2021-09-10 | Metagenomi Ip Technologies, Llc | Class ii, type v crispr systems |
| CA3252595A1 (en) * | 2022-05-25 | 2023-11-30 | Metagenomi Therapeutics, Inc. | LIVER ENZYME EXPRESSION SUPPLEMENTATION |
| EP4705464A2 (en) * | 2023-05-03 | 2026-03-11 | Metagenomi, Inc. | Base editing enzymes |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021178933A2 (en) * | 2020-03-06 | 2021-09-10 | Metagenomi Ip Technologies, Llc | Class ii, type v crispr systems |
| MX2018010484A (es) * | 2016-03-04 | 2019-01-10 | Editas Medicine Inc | Métodos, composiciones y componentes relacionados con crispr-cpf1 para la inmunoterapia contra el cáncer. |
| US11952408B2 (en) * | 2017-10-03 | 2024-04-09 | Juno Therapeutics, Inc. | HPV-specific binding molecules |
| AU2019243315A1 (en) * | 2018-03-29 | 2020-09-24 | Fate Therapeutics, Inc. | Engineered immune effector cells and use thereof |
| WO2020030984A2 (en) * | 2018-08-09 | 2020-02-13 | G+Flas Life Sciences | Compositions and methods for genome engineering with cas12a proteins |
| JP7689949B2 (ja) * | 2019-10-03 | 2025-06-09 | アーティサン ディベロップメント ラブズ インコーポレイテッド | 操作されたデュアルガイド核酸を有するcrisprシステム |
| CN110684823A (zh) * | 2019-10-23 | 2020-01-14 | 海南大学 | 一种基于试纸条的Cas12a酶的微生物快速诊断技术 |
| CN114867485A (zh) * | 2019-10-31 | 2022-08-05 | 全国儿童医院研究所 | Cd38敲除的原代和扩增的人nk细胞的生成 |
| CN110904239B (zh) * | 2019-12-25 | 2020-11-10 | 武汉博杰生物医学科技有限公司 | 肺癌相关分子标志物基因突变的检测试剂盒与检测方法 |
| WO2022056489A1 (en) * | 2020-09-14 | 2022-03-17 | Vor Biopharma, Inc. | Compositions and methods for cd38 modification |
-
2022
- 2022-06-01 MX MX2023014356A patent/MX2023014356A/es unknown
- 2022-06-01 WO PCT/US2022/031849 patent/WO2022256462A1/en not_active Ceased
- 2022-06-01 BR BR112023024983A patent/BR112023024983A2/pt unknown
- 2022-06-01 AU AU2022284808A patent/AU2022284808A1/en active Pending
- 2022-06-01 KR KR1020237045148A patent/KR20240017367A/ko active Pending
- 2022-06-01 CA CA3219187A patent/CA3219187A1/en active Pending
- 2022-06-01 EP EP22816809.2A patent/EP4347816A4/en active Pending
- 2022-06-01 JP JP2023572062A patent/JP2024522086A/ja active Pending
-
2023
- 2023-11-30 US US18/524,511 patent/US20240218339A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12391722B2 (en) | Stabilized nucleic acids encoding messenger ribonucleic acid (mRNA) | |
| TWI835719B (zh) | 經修飾之嚮導rna | |
| FI3802807T3 (fi) | Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja menetelmiä niiden käyttämiseksi | |
| CA3230927A1 (en) | Guide rnas with chemical modification for prime editing | |
| JP2024517607A5 (cg-RX-API-DMAC7.html) | ||
| JP2024506375A5 (cg-RX-API-DMAC7.html) | ||
| CN104711257B (zh) | 用于乙型肝炎病毒感染治疗的导向rna靶点 | |
| Lennox et al. | Chemical modifications in RNA interference and CRISPR/Cas genome editing reagents | |
| CN109971755B (zh) | 一种基于CRISPR/Cas9基因编辑技术的靶向肿瘤的基因治疗药物及其用途 | |
| US20240218339A1 (en) | Class ii, type v crispr systems | |
| US20060134658A1 (en) | Use of RNA trans-splicing for generation of interfering RNA molecules | |
| CN103667347A (zh) | 一种高效表达抗癌基因的受特定miRNA调控的在胶质瘤细胞中特异增殖的腺病毒及其用途 | |
| Jedrzejczyk et al. | Designing synthetic RNA for delivery by nanoparticles | |
| JP2024532784A5 (cg-RX-API-DMAC7.html) | ||
| WO2020044186A2 (en) | Products and compositions | |
| Pérez et al. | MicroRNA interference | |
| Chang et al. | CircRNA knockout/knockdown tools in molecular biology research | |
| Roshan Mehr et al. | Recent Developments in RNA Therapeutics for Humans Disorders | |
| Martin et al. | Nucleic Acid-Based Systems for Regenerative Medicine | |
| WO2025180435A1 (en) | Ligation of nucleic acid molecules and the use thereof for genome editing | |
| HK40029231A (en) | Stabilized nucleic acids encoding messenger ribonucleic acid (mrna) | |
| Sopic | RNA therapeutics in atherosclerosis | |
| CN120004994A (zh) | 一种胞嘧啶脱氨酶抑制剂SflSddi及其应用 | |
| CN116694638A (zh) | 环状核酸应用-miRNA抑制剂 | |
| JP2026078993A (ja) | 標的ヌクレオチド配列の改変のための二本鎖ヌクレオチド複合体 |